Skip to content

Sana Biotechnology SANA Cash Flow Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$241.99M+0.9%-$244.17M-4.2%-$234.41M+7.0%-$252.18M-20.9%-$208.67M+21.8%
$24.1M-5.3%$25.46M-0.4%$25.56M-17.2%$30.86M-13.3%$35.61M-5.5%
-$132.55M+7.8%-$143.83M+9.2%-$158.35M+12.4%-$180.74M+12.3%-$206.18M+7.6%
$17.72M-47.0%
-$7.4M+81.6%-$40.24M-272%$23.35M
$127.62M-0.9%$128.73M+15.2%$111.73M+2,518%$4.27M-70.2%$14.33M-92.8%
-$133.64M+7.7%-$144.77M+8.9%-$158.85M+14.3%-$185.29M+17.2%-$223.9M+12.7%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Sana Biotechnology generate?
Sana Biotechnology (SANA) generated -$132.6M in operating cash flow over the trailing twelve months.
What is Sana Biotechnology's free cash flow?
After $1.3M of capital expenditures, Sana Biotechnology's free cash flow was -$133.6M over the trailing twelve months, up 40.3% year over year.
Where does Sana Biotechnology's cash flow data come from?
Every line is extracted from Sana Biotechnology's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.